Publications
Latest from the sector
JACIE Accreditation: A Consolidated International Model for Quality in Transpla…
CAR-T Access Across Europe: Disparities Between Regulatory Approval and Clinica…
EBMT 2024 Report: One Million Transplants and 20,000 CAR-T Therapies, a Cellula…
OhioHealth: Blood and Marrow Transplant Program Awarded FACT Accreditation
Quality, Training, Research and Artificial Intelligence for Healthcare
We simplify quality management and information security through methods, proprietary tools and continuing education
The ICMED Ecosystem
We are not just consultants. We are an integrated ecosystem where every service empowers the others.
Consulting
International reference for consulting to healthcare facilities, research centres and pharmaceutical companies: JACIE/FACT accreditation, CAR-T, ART, ISO 15189, GCP and GMP.
Training
National ECM provider (ID: 7158). Accredited courses for healthcare professionals in transplants, cellular therapies, quality management and regulatory compliance.
IAAPP
ICMED's proprietary platform for complete quality system management: digital inspections, JACIE/FACT checklists, non-conformity tracking and automatic report generation. The technological edge our competitors don't have.
Magazine
The ICMED scientific journal (ISSN 3103-1943) with peer-reviewed articles on quality, cell therapy, accreditation and healthcare innovation.
ICMED S.r.l. is a private company based in Italy, founded in 2017, offering research, training and consulting services for research centres, stem cell transplant programs, gene therapy centres, fertility centres and hospitals. We are present on three continents (Europe, Africa and the Middle East) and serve over 100 clients.
20+
Years of experience
100+
Clients served
500+
Trained professionals
3
Continents
ICMED Consulting
JACIE/FACT accreditation, CAR-T consulting, PMA programmes, ISO 15189, transfusion services and more. We support healthcare facilities, research centres and pharmaceutical companies across 3 continents.
Book a strategy consultation
Our expertise
JACIE/FACT
CAR-T
CNT/CNS
ISO 15189
PMA
GMP/GCP
ISO 9001
ISO 27001
UNI/PdR 125
Why ICMED
Certifications, accreditations and a consistent growth path since 2017
100%
Inspection success rate
41
Facilities supported
5
Countries
28+
Update courses delivered
Provider ECM 7158
ISO 9001:2015
ISO/IEC 27001:2024
UNI/PdR 125:2022
ISSN 3103-1943
ACN QC1 (in progress)
12+ publications and EBMT/ASH congresses →
2017
ICMED S.r.l. founded — consulting for Transplant Programmes, CAR-T, PMA, JACIE/FACT, GCP and GMP accreditation
2019
Launch of training pathways for Transfusion Services, Cell Therapy, Phase 1 Centres and PMA. First qualification programmes
2022
Qualified as provisional national ECM Provider with AGENAS ID 7158
2023
Launch of the quality management platform — IAAPP
2024
Middle East market entry: Qatar, UAE, Kuwait
2025
Launch of ICMEDU365 e-learning platform. ICMED Magazine founded
2026
ISSN 3103-1943 for ICMED Magazine. Definitive ECM Provider. ISO/IEC 27001:2024 and UNI/PdR 125:2022 certifications
News & Activities
Latest news and scientific activities
Publications
CAR-T Access Across Europe: Disparities Between Regulatory Approval and Clinical Availability
The ICMED perspective
Healthcare facilities must recognize that regulatory approval alone guarantees neither clinical availability nor patient access. Harmonizing JACIE/FACT standards and reimbursement pathways across Europe is critical to eliminate geographic disparities and ensure consistent, equitable CAR-T delivery capabilities.
Publications
EBMT 2024 Report: One Million Transplants and 20,000 CAR-T Therapies, a Cellular Medicine Landmark
The ICMED perspective
Healthcare facilities must recognize that this one-million-transplant milestone validates JACIE accreditation's critical role in maintaining safety and efficacy standards across complex cellular therapies. Achieving and maintaining accreditation directly enhances institutional credibility, supports regulatory compliance, and positions facilities to deliver proven-quality CAR-T and transplant programs.
Scientific Insights & Magazine
ICMED Magazine (ISSN 3103-1943) — the scientific journal dedicated to quality and innovation in healthcare
JACIE accreditation's international standardization strengthens transplant centre credibility and patient safety outcomes across borders. Facilities pursuing or maintaining JACIE certification gain evidence-based validation that their quality systems meet globally recognized benchmarks for haematopoietic stem cell transplantation excellence.